Metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: Reassessment of expected [18F]-fluorodeoxyglucose uptake patterns

Clinical assessment of frontotemporal lobar degeneration (FTLD)/primary progressive aphasia (PPA) patients is challenging, given that common cognitive assessments rely extensively on language. Since asymmetry in neuroimaging biomarkers is often described as a central finding in these patients, our s...

Full description

Bibliographic Details
Main Authors: Ana M Franceschi, Kiyon Naser-Tavakolian, Michael Clifton, Lev Bangiyev, Giuseppe Cruciata, Sean Clouston, Dinko Franceschi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:World Journal of Nuclear Medicine
Subjects:
Online Access:http://www.wjnm.org/article.asp?issn=1450-1147;year=2021;volume=20;issue=3;spage=294;epage=304;aulast=
id doaj-adc3cb796ba64be9b9436602fff66486
record_format Article
spelling doaj-adc3cb796ba64be9b9436602fff664862021-10-07T06:58:15ZengWolters Kluwer Medknow PublicationsWorld Journal of Nuclear Medicine1450-11471607-33122021-01-0120329430410.4103/wjnm.wjnm_137_20Metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: Reassessment of expected [18F]-fluorodeoxyglucose uptake patternsAna M FranceschiKiyon Naser-TavakolianMichael CliftonLev BangiyevGiuseppe CruciataSean CloustonDinko FranceschiClinical assessment of frontotemporal lobar degeneration (FTLD)/primary progressive aphasia (PPA) patients is challenging, given that common cognitive assessments rely extensively on language. Since asymmetry in neuroimaging biomarkers is often described as a central finding in these patients, our study evaluated [18F]-fluorodeoxyglucose (FDG) uptake patterns in patients meeting clinical and imaging criteria for FTLD, with emphasis on PPA. Fifty-one subjects underwent brain [18F]-FDG positron-emission tomography/magnetic resonance imaging (PET/MRI) as part of their routine clinical workup for dementia and neurodegenerative disease. Images were obtained using a Siemens Biograph mMR integrated 3T PET/MRI scanner. PET surface maps and fusion fluid-attenuated inversion recovery-PET images were generated utilizing MIMneuro software. Two board-certified neuroradiologists and one nuclear medicine physician blinded to patient history classified each FTLD/PPA subtype and assessed for left- versus right-side dominant hypometabolism. Qualitative and semiquantitative assessment demonstrated 18 cases of PPA, 16 behavioral variant frontotemporal dementia (bvFTD), 12 corticobasal degeneration, and 5 progressive supranuclear palsy. Among the 18 PPA subjects (11 svPPA, 5 lvPPA, and 2 agPPA), 12 (67%) demonstrated left-dominant hypometabolism and 6 (33%) right-dominant hypometabolism. While existing literature stresses left-dominant hypometabolism as a key imaging feature in the PPA subtypes, a third of our cases demonstrated right-dominant hypometabolism, suggesting that emphasis should be placed on the functionality of specific brain regions affected, rather than left versus right sidedness of hypometabolism patterns.http://www.wjnm.org/article.asp?issn=1450-1147;year=2021;volume=20;issue=3;spage=294;epage=304;aulast=[18f]-fluorodeoxyglucosefrontotemporal lobar degenerationhybrid neuroimagingpositron emission tomography/magnetic resonance imagingprimary progressive aphasia
collection DOAJ
language English
format Article
sources DOAJ
author Ana M Franceschi
Kiyon Naser-Tavakolian
Michael Clifton
Lev Bangiyev
Giuseppe Cruciata
Sean Clouston
Dinko Franceschi
spellingShingle Ana M Franceschi
Kiyon Naser-Tavakolian
Michael Clifton
Lev Bangiyev
Giuseppe Cruciata
Sean Clouston
Dinko Franceschi
Metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: Reassessment of expected [18F]-fluorodeoxyglucose uptake patterns
World Journal of Nuclear Medicine
[18f]-fluorodeoxyglucose
frontotemporal lobar degeneration
hybrid neuroimaging
positron emission tomography/magnetic resonance imaging
primary progressive aphasia
author_facet Ana M Franceschi
Kiyon Naser-Tavakolian
Michael Clifton
Lev Bangiyev
Giuseppe Cruciata
Sean Clouston
Dinko Franceschi
author_sort Ana M Franceschi
title Metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: Reassessment of expected [18F]-fluorodeoxyglucose uptake patterns
title_short Metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: Reassessment of expected [18F]-fluorodeoxyglucose uptake patterns
title_full Metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: Reassessment of expected [18F]-fluorodeoxyglucose uptake patterns
title_fullStr Metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: Reassessment of expected [18F]-fluorodeoxyglucose uptake patterns
title_full_unstemmed Metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: Reassessment of expected [18F]-fluorodeoxyglucose uptake patterns
title_sort metabolic positron-emission tomography/magnetic resonance imaging in primary progressive aphasia and frontotemporal lobar degeneration subtypes: reassessment of expected [18f]-fluorodeoxyglucose uptake patterns
publisher Wolters Kluwer Medknow Publications
series World Journal of Nuclear Medicine
issn 1450-1147
1607-3312
publishDate 2021-01-01
description Clinical assessment of frontotemporal lobar degeneration (FTLD)/primary progressive aphasia (PPA) patients is challenging, given that common cognitive assessments rely extensively on language. Since asymmetry in neuroimaging biomarkers is often described as a central finding in these patients, our study evaluated [18F]-fluorodeoxyglucose (FDG) uptake patterns in patients meeting clinical and imaging criteria for FTLD, with emphasis on PPA. Fifty-one subjects underwent brain [18F]-FDG positron-emission tomography/magnetic resonance imaging (PET/MRI) as part of their routine clinical workup for dementia and neurodegenerative disease. Images were obtained using a Siemens Biograph mMR integrated 3T PET/MRI scanner. PET surface maps and fusion fluid-attenuated inversion recovery-PET images were generated utilizing MIMneuro software. Two board-certified neuroradiologists and one nuclear medicine physician blinded to patient history classified each FTLD/PPA subtype and assessed for left- versus right-side dominant hypometabolism. Qualitative and semiquantitative assessment demonstrated 18 cases of PPA, 16 behavioral variant frontotemporal dementia (bvFTD), 12 corticobasal degeneration, and 5 progressive supranuclear palsy. Among the 18 PPA subjects (11 svPPA, 5 lvPPA, and 2 agPPA), 12 (67%) demonstrated left-dominant hypometabolism and 6 (33%) right-dominant hypometabolism. While existing literature stresses left-dominant hypometabolism as a key imaging feature in the PPA subtypes, a third of our cases demonstrated right-dominant hypometabolism, suggesting that emphasis should be placed on the functionality of specific brain regions affected, rather than left versus right sidedness of hypometabolism patterns.
topic [18f]-fluorodeoxyglucose
frontotemporal lobar degeneration
hybrid neuroimaging
positron emission tomography/magnetic resonance imaging
primary progressive aphasia
url http://www.wjnm.org/article.asp?issn=1450-1147;year=2021;volume=20;issue=3;spage=294;epage=304;aulast=
work_keys_str_mv AT anamfranceschi metabolicpositronemissiontomographymagneticresonanceimaginginprimaryprogressiveaphasiaandfrontotemporallobardegenerationsubtypesreassessmentofexpected18ffluorodeoxyglucoseuptakepatterns
AT kiyonnasertavakolian metabolicpositronemissiontomographymagneticresonanceimaginginprimaryprogressiveaphasiaandfrontotemporallobardegenerationsubtypesreassessmentofexpected18ffluorodeoxyglucoseuptakepatterns
AT michaelclifton metabolicpositronemissiontomographymagneticresonanceimaginginprimaryprogressiveaphasiaandfrontotemporallobardegenerationsubtypesreassessmentofexpected18ffluorodeoxyglucoseuptakepatterns
AT levbangiyev metabolicpositronemissiontomographymagneticresonanceimaginginprimaryprogressiveaphasiaandfrontotemporallobardegenerationsubtypesreassessmentofexpected18ffluorodeoxyglucoseuptakepatterns
AT giuseppecruciata metabolicpositronemissiontomographymagneticresonanceimaginginprimaryprogressiveaphasiaandfrontotemporallobardegenerationsubtypesreassessmentofexpected18ffluorodeoxyglucoseuptakepatterns
AT seanclouston metabolicpositronemissiontomographymagneticresonanceimaginginprimaryprogressiveaphasiaandfrontotemporallobardegenerationsubtypesreassessmentofexpected18ffluorodeoxyglucoseuptakepatterns
AT dinkofranceschi metabolicpositronemissiontomographymagneticresonanceimaginginprimaryprogressiveaphasiaandfrontotemporallobardegenerationsubtypesreassessmentofexpected18ffluorodeoxyglucoseuptakepatterns
_version_ 1716839594750640128